Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma

Gayathri Heenatigala Palliyage, Somnath Singh, Charles R. Ashby, Amit K. Tiwari, Harsh Chauhan

Research output: Contribution to journalReview article

Abstract

Melanoma is regarded as the fifth and sixth most common cancer in men and women, respectively, and it is estimated that one person dies from melanoma every hour in the USA. Unfortunately, the treatment of melanoma is difficult because of its aggressive metastasis and resistance to treatment. The treatment of melanoma continues to be a challenging issue due to the limitations of available treatments such as a low response rate, severe adverse reactions, and significant toxicity. Natural polyphenols have attracted considerable attention from the scientific community due to their chemopreventive and chemotherapeutic efficacy. It has been suggested that poorly soluble polyphenols such as curcumin, resveratrol, quercetin, coumarin, and epigallocatechin-3-gallate may have significant benefits in the treatment of melanoma due to their antioxidant, anti-inflammatory, antiproliferative, and chemoprotective efficacies. The major obstacles for the use of polyphenolic compounds are low stability and poor bioavailability. Numerous nanoformulations, including solid lipid nanoparticles, polymeric nanoparticles, micelles, and liposomes, have been formulated to enhance the bioavailability and stability, as well as the therapeutic efficacy of polyphenols. This review will provide an overview of poorly soluble polyphenols that have been reported to have antimetastatic efficacy in melanomas.

Original languageEnglish (US)
Article number250
JournalAAPS PharmSciTech
Volume20
Issue number6
DOIs
StatePublished - Aug 1 2019

Fingerprint

Polyphenols
Melanoma
Pharmaceutical Preparations
Nanoparticles
Biological Availability
Therapeutics
Curcumin
Quercetin
Micelles
Liposomes
Anti-Inflammatory Agents
Antioxidants
Neoplasm Metastasis
Lipids
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols : Potential Role in Prevention and Treatment of Melanoma. / Heenatigala Palliyage, Gayathri; Singh, Somnath; Ashby, Charles R.; Tiwari, Amit K.; Chauhan, Harsh.

In: AAPS PharmSciTech, Vol. 20, No. 6, 250, 01.08.2019.

Research output: Contribution to journalReview article

Heenatigala Palliyage, Gayathri ; Singh, Somnath ; Ashby, Charles R. ; Tiwari, Amit K. ; Chauhan, Harsh. / Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols : Potential Role in Prevention and Treatment of Melanoma. In: AAPS PharmSciTech. 2019 ; Vol. 20, No. 6.
@article{c37d2934d169496da30ce998a21ac57f,
title = "Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma",
abstract = "Melanoma is regarded as the fifth and sixth most common cancer in men and women, respectively, and it is estimated that one person dies from melanoma every hour in the USA. Unfortunately, the treatment of melanoma is difficult because of its aggressive metastasis and resistance to treatment. The treatment of melanoma continues to be a challenging issue due to the limitations of available treatments such as a low response rate, severe adverse reactions, and significant toxicity. Natural polyphenols have attracted considerable attention from the scientific community due to their chemopreventive and chemotherapeutic efficacy. It has been suggested that poorly soluble polyphenols such as curcumin, resveratrol, quercetin, coumarin, and epigallocatechin-3-gallate may have significant benefits in the treatment of melanoma due to their antioxidant, anti-inflammatory, antiproliferative, and chemoprotective efficacies. The major obstacles for the use of polyphenolic compounds are low stability and poor bioavailability. Numerous nanoformulations, including solid lipid nanoparticles, polymeric nanoparticles, micelles, and liposomes, have been formulated to enhance the bioavailability and stability, as well as the therapeutic efficacy of polyphenols. This review will provide an overview of poorly soluble polyphenols that have been reported to have antimetastatic efficacy in melanomas.",
author = "{Heenatigala Palliyage}, Gayathri and Somnath Singh and Ashby, {Charles R.} and Tiwari, {Amit K.} and Harsh Chauhan",
year = "2019",
month = "8",
day = "1",
doi = "10.1208/s12249-019-1457-1",
language = "English (US)",
volume = "20",
journal = "AAPS PharmSciTech",
issn = "1530-9932",
publisher = "American Association of Pharmaceutical Scientists",
number = "6",

}

TY - JOUR

T1 - Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols

T2 - Potential Role in Prevention and Treatment of Melanoma

AU - Heenatigala Palliyage, Gayathri

AU - Singh, Somnath

AU - Ashby, Charles R.

AU - Tiwari, Amit K.

AU - Chauhan, Harsh

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Melanoma is regarded as the fifth and sixth most common cancer in men and women, respectively, and it is estimated that one person dies from melanoma every hour in the USA. Unfortunately, the treatment of melanoma is difficult because of its aggressive metastasis and resistance to treatment. The treatment of melanoma continues to be a challenging issue due to the limitations of available treatments such as a low response rate, severe adverse reactions, and significant toxicity. Natural polyphenols have attracted considerable attention from the scientific community due to their chemopreventive and chemotherapeutic efficacy. It has been suggested that poorly soluble polyphenols such as curcumin, resveratrol, quercetin, coumarin, and epigallocatechin-3-gallate may have significant benefits in the treatment of melanoma due to their antioxidant, anti-inflammatory, antiproliferative, and chemoprotective efficacies. The major obstacles for the use of polyphenolic compounds are low stability and poor bioavailability. Numerous nanoformulations, including solid lipid nanoparticles, polymeric nanoparticles, micelles, and liposomes, have been formulated to enhance the bioavailability and stability, as well as the therapeutic efficacy of polyphenols. This review will provide an overview of poorly soluble polyphenols that have been reported to have antimetastatic efficacy in melanomas.

AB - Melanoma is regarded as the fifth and sixth most common cancer in men and women, respectively, and it is estimated that one person dies from melanoma every hour in the USA. Unfortunately, the treatment of melanoma is difficult because of its aggressive metastasis and resistance to treatment. The treatment of melanoma continues to be a challenging issue due to the limitations of available treatments such as a low response rate, severe adverse reactions, and significant toxicity. Natural polyphenols have attracted considerable attention from the scientific community due to their chemopreventive and chemotherapeutic efficacy. It has been suggested that poorly soluble polyphenols such as curcumin, resveratrol, quercetin, coumarin, and epigallocatechin-3-gallate may have significant benefits in the treatment of melanoma due to their antioxidant, anti-inflammatory, antiproliferative, and chemoprotective efficacies. The major obstacles for the use of polyphenolic compounds are low stability and poor bioavailability. Numerous nanoformulations, including solid lipid nanoparticles, polymeric nanoparticles, micelles, and liposomes, have been formulated to enhance the bioavailability and stability, as well as the therapeutic efficacy of polyphenols. This review will provide an overview of poorly soluble polyphenols that have been reported to have antimetastatic efficacy in melanomas.

UR - http://www.scopus.com/inward/record.url?scp=85068870761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068870761&partnerID=8YFLogxK

U2 - 10.1208/s12249-019-1457-1

DO - 10.1208/s12249-019-1457-1

M3 - Review article

AN - SCOPUS:85068870761

VL - 20

JO - AAPS PharmSciTech

JF - AAPS PharmSciTech

SN - 1530-9932

IS - 6

M1 - 250

ER -